{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.90G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "90"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005315"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and inhibitor treatment",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "PC12/TetOn",
        "Description": "Inducible model in PC12/TetOn cells expressing WT or A30P alpha-synuclein"
      },
      "Readout type": "Qualitative and Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.90G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A30P variant showed increased aggregation and toxicity compared to WT under 3-MA and MG132 treatments"
        },
        {
          "Variant": "WT",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Wild-type alpha-synuclein exhibited lower aggregation and maintained antioxidant function"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal readout defined by absence of aggregation and maintained antioxidant function",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal readout defined by increased aggregation and reduced antioxidant function",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}